Analystreport

Acorda Therapeutics, Inc. (NASDAQ: ACOR) had its price target raised by analysts at Cowen Inc from $5.00 to $35.00.

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors